MelioLabs

Melio develops a culture-free, rapid bloodborne pathogen testing platform designed to identify pathogens in hours rather than days. The technology integrates a proprietary assay, microfluidics, and machine-learning techniques to enable direct-from-blood diagnostic testing without the need for targeted probes. The system utilizes DNA melting technol... ogy to capture unique DNA melt curves, which are then classified via AI-driven analytics. Melio specifically targets applications for newborns in the NICU to reduce the use of unnecessary antibiotics. The solution is designed to detect Gram-positive and Gram-negative bacteria, fungi, viruses, and antimicrobial resistance markers, with new detection capabilities delivered via software updates.Read More